BeyondSpring Inc. Stock-Based Compensation
BeyondSpring Inc. (BYSI) reported Stock-Based Compensation of $1.04 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2026-08-14
- BeyondSpring Inc. share-based payment arrangement, noncash expense for the quarter ending 2026-06-30 was $575.00K, a 296.55% increase year-over-year.
- BeyondSpring Inc. share-based payment arrangement, noncash expense for the quarter ending 2026-03-31 was $461.00K, a 88.93% increase year-over-year.
- BeyondSpring Inc. share-based payment arrangement, noncash expense for the quarter ending 2025-12-31 was $167.00K, a 58.15% decline year-over-year.
- BeyondSpring Inc. share-based payment arrangement, noncash expense for the quarter ending 2025-09-30 was $166.00K, a 79.93% decline year-over-year.
- BeyondSpring Inc. share-based payment arrangement, noncash expense for fiscal 2025 was $722.00K, a 67.98% decline from fiscal 2024.
- BeyondSpring Inc. share-based payment arrangement, noncash expense for fiscal 2024 was $2.25M, a 192.86% increase from fiscal 2023.
- BeyondSpring Inc. share-based payment arrangement, noncash expense for fiscal 2023 was $770.00K.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $575.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $1.04M 10-Q · filed 2026-08-14 | $1.20M derived: sum of 3 quarters · filed 2026-08-14 | $1.37M derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | $461.00K 10-Q · filed 2026-05-13 | $628.00K derived: sum of 2 quarters · filed 2026-05-13 | $794.00K derived: sum of 3 quarters · filed 2026-05-13 | $939.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-12-31 | $167.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $333.00K derived: sum of 2 quarters · filed 2026-03-25 | $478.00K derived: sum of 3 quarters · filed 2026-08-14 | $722.00K 10-K · filed 2026-03-25 |
| 2025-09-30 | $166.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $311.00K derived: sum of 2 quarters · filed 2026-08-14 | $555.00K 10-Q · filed 2025-11-12 | $954.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | $145.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $389.00K 10-Q · filed 2026-08-14 | $788.00K derived: sum of 3 quarters · filed 2026-08-14 | $1.61M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | $244.00K 10-Q · filed 2026-05-13 | $643.00K derived: sum of 2 quarters · filed 2026-05-13 | $1.47M derived: sum of 3 quarters · filed 2026-05-13 | $2.25M derived: sum of 4 quarters · filed 2026-05-13 |
| 2024-12-31 | $399.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $1.23M derived: sum of 2 quarters · filed 2026-03-25 | $2.00M derived: sum of 3 quarters · filed 2026-03-25 | $2.25M 10-K · filed 2026-03-25 |
| 2024-09-30 | $827.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $1.60M derived: sum of 2 quarters · filed 2025-11-12 | $1.86M 10-Q · filed 2025-11-12 | |
| 2024-06-30 | $778.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | $1.03M 10-Q · filed 2025-08-13 | ||
| 2024-03-31 | $251.00K 10-Q · filed 2025-05-12 | |||
| 2023-12-31 | $770.00K 10-K · filed 2025-03-27 | |||
| 2022-12-31 | $1.67M 20-F · filed 2023-04-18 | |||
| 2021-12-31 | -$2.14M derived: 20-F 12 month − 6-K 9 month · filed 2023-04-18 | -$396.00K derived: sum of 2 quarters · filed 2023-04-18 | $2.03M derived: sum of 3 quarters · filed 2023-04-18 | $3.15M 20-F · filed 2023-04-18 |
| 2021-09-30 | $1.74M derived: 6-K 9 month − 6-K 6 month · filed 2021-12-30 | $4.17M derived: sum of 2 quarters · filed 2021-12-30 | $5.29M 6-K · filed 2021-12-30 | $7.40M derived: sum of 4 quarters · filed 2023-04-18 |
| 2021-06-30 | $2.43M derived: 6-K 6 month − 6-K 3 month · filed 2021-09-10 | $3.55M 6-K · filed 2021-09-10 | $5.66M derived: sum of 3 quarters · filed 2023-04-18 | $7.44M derived: sum of 4 quarters · filed 2023-04-18 |
| 2021-03-31 | $1.12M 6-K · filed 2021-06-16 | $3.23M derived: sum of 2 quarters · filed 2023-04-18 | $5.01M derived: sum of 3 quarters · filed 2023-04-18 | $5.85M derived: sum of 4 quarters · filed 2023-04-18 |
| 2020-12-31 | $2.11M derived: 20-F 12 month − 6-K 9 month · filed 2023-04-18 | $3.89M derived: sum of 2 quarters · filed 2023-04-18 | $4.72M derived: sum of 3 quarters · filed 2023-04-18 | $8.19M 20-F · filed 2023-04-18 |
| 2020-09-30 | $1.78M derived: 6-K 9 month − 6-K 6 month · filed 2021-12-30 | $2.61M derived: sum of 2 quarters · filed 2021-12-30 | $6.08M 6-K · filed 2021-12-30 | $6.43M derived: sum of 4 quarters · filed 2022-04-14 |
| 2020-06-30 | $836.00K derived: 6-K 6 month − 6-K 3 month · filed 2021-09-10 | $4.31M 6-K · filed 2021-09-10 | $4.66M derived: sum of 3 quarters · filed 2022-04-14 | $5.12M derived: sum of 4 quarters · filed 2022-04-14 |
| 2020-03-31 | $3.47M 6-K · filed 2021-06-16 | $3.82M derived: sum of 2 quarters · filed 2022-04-14 | $4.28M derived: sum of 3 quarters · filed 2022-04-14 | $5.20M derived: sum of 4 quarters · filed 2022-04-14 |
| 2019-12-31 | $351.00K derived: 20-F 12 month − 6-K 9 month · filed 2022-04-14 | $814.00K derived: sum of 2 quarters · filed 2022-04-14 | $1.73M derived: sum of 3 quarters · filed 2022-04-14 | $2.10M 20-F · filed 2022-04-14 |
| 2019-09-30 | $463.00K derived: 6-K 9 month − 6-K 6 month · filed 2020-11-17 | $1.38M derived: sum of 2 quarters · filed 2020-11-17 | $1.75M 6-K · filed 2020-11-17 | $2.27M derived: sum of 4 quarters · filed 2021-04-30 |
| 2019-06-30 | $916.00K derived: 6-K 6 month − 6-K 3 month · filed 2020-09-03 | $1.29M 6-K · filed 2020-09-03 | $1.81M derived: sum of 3 quarters · filed 2021-04-30 | $2.65M derived: sum of 4 quarters · filed 2021-04-30 |
| 2019-03-31 | $371.00K 6-K · filed 2020-06-11 | $890.00K derived: sum of 2 quarters · filed 2021-04-30 | $1.74M derived: sum of 3 quarters · filed 2021-04-30 | $2.73M derived: sum of 4 quarters · filed 2021-04-30 |
| 2018-12-31 | $519.00K derived: 20-F 12 month − 6-K 9 month · filed 2021-04-30 | $1.37M derived: sum of 2 quarters · filed 2021-04-30 | $2.36M derived: sum of 3 quarters · filed 2021-04-30 | $6.56M 20-F · filed 2021-04-30 |
| 2018-09-30 | $848.00K derived: 6-K 9 month − 6-K 6 month · filed 2019-12-18 | $1.84M derived: sum of 2 quarters · filed 2019-12-18 | $6.04M 6-K · filed 2019-12-18 | $9.86M derived: sum of 4 quarters · filed 2020-04-30 |
| 2018-06-30 | $992.00K derived: 6-K 6 month − 6-K 3 month · filed 2019-09-18 | $5.19M 6-K · filed 2019-09-18 | $9.01M derived: sum of 3 quarters · filed 2020-04-30 | $19.12M derived: sum of 4 quarters · filed 2020-04-30 |
| 2018-03-31 | $4.20M 6-K · filed 2019-07-10 | $8.02M derived: sum of 2 quarters · filed 2020-04-30 | $18.13M derived: sum of 3 quarters · filed 2020-04-30 | |
| 2017-12-31 | $3.82M derived: 20-F 12 month − 6-K 9 month · filed 2020-04-30 | $13.93M derived: sum of 2 quarters · filed 2020-04-30 | $22.68M 20-F · filed 2020-04-30 | |
| 2017-09-30 | $10.11M derived: 6-K 9 month − 6-K 6 month · filed 2017-11-09 | $18.86M 6-K · filed 2017-11-09 | ||
| 2017-06-30 | $8.76M 6-K · filed 2018-10-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |